Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Analysts See Threat To Intuitive Surgical From Third-Party Repair Businesses

Executive Summary

Intuitive Surgical’s da Vinci robotic-assisted surgery system is facing a new competitor that may be harder to beat than the robotic-assisted surgery systems created by other companies. According to analysts, a growing number of hospitals will begin to use repaired da Vinci instruments supplied by third-parties, which could potentially impede the growth of Intuitive’s business.

You may also be interested in...



J&J Has Big Plans For Robotic Surgery In 2020

The company’s leadership discussed its recent investments in robotic surgery technology during Johnson & Johnson’s 2019 fourth-quarter earnings call on 22 January. The company will provide more information on its robotic surgery platforms at its investors meeting in May in New York.

Study Shows Rapid Adoption Of Robotic Assistance For Unproven Procedures

The authors of a large cohort study of the uptake of robotic-assisted surgery in Michigan hospitals argue that the rapid adoption of robotic techniques is not supported by existing clinical evidence.

Medtronic Introduces Hugo To Rival Intuitive's Robotic Surgery System

The company unveiled its new modular robotic surgery system for minimally invasive surgery at a special event in Hartford, CT. Medtronic expects the new system to earn a CE mark by early 2021 and FDA approval by the end of 2021.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT126179

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel